Palapas, Nestor H.

HRN: 22-95-24  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/23/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
04/23/2023
04/30/2023
IV
600mg
Q8hours
Empiric
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Skin & Soft TissueCardiovascularProphylaxis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: